Eargo 6 vs Elehear Beyond

The Eargo 6 is a premium-priced OTC hearing aid ($2,250) that earns a B grade with a SoundScore of 3.4/5 in our lab testing. This invisible-in-ear device ranks #42 of 65 OTC hearing aids tested, placing it in the top 63% of its category. In our standardized testing, the Eargo 6 demonstrates solid speech clarity in quiet environments, scoring 3.3/5—notably 0.53 points above the OTC category average. Own-voice comfort also performs above category average at 2.9/5, which may benefit users sensitive to the sound of their own voice. However, the device shows limitations in challenging listening situations, with speech-in-noise performance scoring 1.0/5, falling 0.48 points below the category average. A significant limitation is music streaming, which scores 0.0/5—well below the category average by 1.92 points. Users who prioritize streaming audio content should consider alternatives. Feedback handling scores 3.3/5, which is solid in absolute terms though 1.24 points below the category average of 4.54/5. The Eargo 6 may appeal to users prioritizing a completely invisible form factor and solid quiet-environment performance. However, at its premium price point, alternatives like the Sony CRE-C10 offer stronger overall performance at a lower price. The rechargeable battery adds convenience, but buyers should weigh the device's limitations in noise and streaming against its aesthetic benefits.

The Elehear Beyond is a behind-the-ear OTC hearing aid priced at $431, earning an A grade with a SoundScore of 4.3/5. This places it in the top 11% of all OTC hearing aids tested, ranking #8 out of 65 devices in its category—a standout result for a budget-tier product. In our lab testing, the Beyond demonstrates particular strength in speech clarity for quiet environments, scoring 4.3/5—a full 1.48 points above the OTC category average. Music streaming quality is another highlight at 3.8/5, measuring 1.88 points above average and delivering solid fidelity for phone audio. Speech understanding in noisy situations scores 2.3/5, which is 0.83 points above the category average but remains mixed in absolute terms—a common limitation among OTC devices. Feedback handling is excellent at 4.5/5, providing stable performance during typical use. Own-voice comfort scores 2.6/5, slightly above the category average but still in mixed territory, which may be noticeable for some users during conversation. The Beyond earned a 2024 Expert's Choice Award and represents strong value in the budget OTC segment. It outperforms several same-price competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni. This device is best suited for those seeking reliable speech clarity in quieter settings and quality streaming audio without the higher cost of prescription alternatives.